These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 34470855)
21. Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans. Bigley AB; Rezvani K; Shah N; Sekine T; Balneger N; Pistillo M; Agha N; Kunz H; O'Connor DP; Bollard CM; Simpson RJ Clin Exp Immunol; 2016 Aug; 185(2):239-51. PubMed ID: 26940026 [TBL] [Abstract][Full Text] [Related]
22. Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction. Muntasell A; Vilches C; Angulo A; López-Botet M Eur J Immunol; 2013 May; 43(5):1133-41. PubMed ID: 23552990 [TBL] [Abstract][Full Text] [Related]
24. Human Cytomegalovirus Antigen Presentation by HLA-DR+ NKG2C+ Adaptive NK Cells Specifically Activates Polyfunctional Effector Memory CD4+ T Lymphocytes. Costa-García M; Ataya M; Moraru M; Vilches C; López-Botet M; Muntasell A Front Immunol; 2019; 10():687. PubMed ID: 31001281 [TBL] [Abstract][Full Text] [Related]
25. Molecular Signatures of Natural Killer Cells in CMV-Associated Anterior Uveitis, A New Type of CMV-Induced Disease in Immunocompetent Individuals. Yawata N; Shirane M; Woon K; Lim X; Tanaka H; Kawano YI; Yawata M; Chee SP; Siak J; Sonoda KH Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807229 [TBL] [Abstract][Full Text] [Related]
26. Adaptive Natural Killer Cell and Killer Cell Immunoglobulin-Like Receptor-Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated with Protection against Cytomegalovirus Reactivation after Allogeneic Donor Hematopoietic Cell Transplantation. Davis ZB; Cooley SA; Cichocki F; Felices M; Wangen R; Luo X; DeFor TE; Bryceson YT; Diamond DJ; Brunstein C; Blazar BR; Wagner JE; Weisdorf DJ; Horowitz A; Guethlein LA; Parham P; Verneris MR; Miller JS Biol Blood Marrow Transplant; 2015 Sep; 21(9):1653-62. PubMed ID: 26055301 [TBL] [Abstract][Full Text] [Related]
27. Characterization of Natural Killer Cell Profile in a Cohort of Infected Pregnant Women and Their Babies and Its Relation to CMV Transmission. Pighi C; Rotili A; De Luca M; Chiurchiù S; Calò Carducci FI; Rossetti C; Cifaldi L; Bei R; Caforio L; Bernardi S; Palma P; Amodio D Viruses; 2024 May; 16(5):. PubMed ID: 38793661 [TBL] [Abstract][Full Text] [Related]
28. Adaptive natural killer cell response to cytomegalovirus and disability progression in multiple sclerosis. Martínez-Rodríguez JE; Cobo-Calvo A; Villar LM; Munteis E; Blanco Y; Rasal R; Vera A; Muntasell A; Alvarez-Lafuente R; Saiz A; Alvarez-Cermeño JC; Martínez-Yélamos S; Roquer J; López-Botet M Mult Scler; 2016 May; 22(6):741-52. PubMed ID: 26362897 [TBL] [Abstract][Full Text] [Related]
30. Spotlight on NKG2C and the human NK-cell response to CMV infection. Malmberg KJ; Beziat V; Ljunggren HG Eur J Immunol; 2012 Dec; 42(12):3141-5. PubMed ID: 23255011 [TBL] [Abstract][Full Text] [Related]
31. Amplified NKG2C+ NK cells in cytomegalovirus (CMV) infection preferentially express killer cell Ig-like receptor 2DL: functional impact in controlling CMV-infected dendritic cells. Djaoud Z; David G; Bressollette C; Willem C; Rettman P; Gagne K; Legrand N; Mehlal S; Cesbron A; Imbert-Marcille BM; Retière C J Immunol; 2013 Sep; 191(5):2708-16. PubMed ID: 23918974 [TBL] [Abstract][Full Text] [Related]
32. Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection. Brunetta E; Fogli M; Varchetta S; Bozzo L; Hudspeth KL; Marcenaro E; Moretta A; Mavilio D AIDS; 2010 Jan; 24(1):27-34. PubMed ID: 19910789 [TBL] [Abstract][Full Text] [Related]
33. Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation After Double Cord Blood Transplantation. Cao K; Marin D; Sekine T; Rondon G; Zhao W; Smith NT; Daher M; Wang Q; Li L; Saliba RM; Pingali R; Popat U; Hosing C; Olson A; Oran B; Basar R; Mehta RS; Champlin R; Shpall EJ; Rezvani K Front Immunol; 2018; 9():2444. PubMed ID: 30405633 [TBL] [Abstract][Full Text] [Related]
34. Late Development of FcεRγ Muccio L; Falco M; Bertaina A; Locatelli F; Frassoni F; Sivori S; Moretta L; Moretta A; Della Chiesa M Front Immunol; 2018; 9():1050. PubMed ID: 29868012 [TBL] [Abstract][Full Text] [Related]
35. Coordinated expansion of both memory T cells and NK cells in response to CMV infection in humans. Bayard C; Lepetitcorps H; Roux A; Larsen M; Fastenackels S; Salle V; Vieillard V; Marchant A; Stern M; Boddaert J; Bajolle F; Appay V; Sauce D Eur J Immunol; 2016 May; 46(5):1168-79. PubMed ID: 26910859 [TBL] [Abstract][Full Text] [Related]
36. Circulating NKG2C + NK cell expressing CD107a/LAMP-1 subsets at the onset of CMV reactivation in seropositive kidney transplant recipients. Soleimanian S; Yaghobi R; Karimi MH; Geramizadeh B; Roozbeh J; Hossein Aghdaie M; Heidari M Transpl Immunol; 2021 Dec; 69():101460. PubMed ID: 34492297 [TBL] [Abstract][Full Text] [Related]
37. Independent skewing of the T cell and NK cell compartments associated with cytomegalovirus infection suggests division of labor between innate and adaptive immunity. Bengnér M; Béziat V; Ernerudh J; Nilsson BO; Löfgren S; Wikby A; Malmberg KJ; Strindhall J Age (Dordr); 2014 Apr; 36(2):571-82. PubMed ID: 24065293 [TBL] [Abstract][Full Text] [Related]
38. Expansion of the NKG2C+ natural killer-cell subset is associated with high-risk carotid atherosclerotic plaques in seropositive patients for human cytomegalovirus. Martínez-Rodríguez JE; Munné-Collado J; Rasal R; Cuadrado E; Roig L; Ois A; Muntasell A; Baro T; Alameda F; Roquer J; López-Botet M Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2653-9. PubMed ID: 23968979 [TBL] [Abstract][Full Text] [Related]
39. Characterization of IFNγ-producing natural killer cells induced by cytomegalovirus reactivation after haploidentical hematopoietic stem cell transplantation. Jin F; Lin H; Gao S; Wang H; Yan H; Guo J; Hu Z; Jin C; Wang Y; Wang Z; Zhao Y; Liu Y; Zheng X; Tan Y; Li W; Dai Y; Yang Y Oncotarget; 2017 Jan; 8(1):51-63. PubMed ID: 27980216 [TBL] [Abstract][Full Text] [Related]
40. HCMV-controlling NKG2C Bozzano F; Della Chiesa M; Pelosi A; Antonini F; Ascierto ML; Del Zotto G; Moretta F; Muccio L; Luganini A; Gribaudo G; Cenderello G; Dentone C; Nicolini L; Moretta A; Moretta L; De Maria A J Allergy Clin Immunol; 2021 Jun; 147(6):2343-2357. PubMed ID: 33493558 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]